Article
Exploiting drug-resistant enzymes as tools to identify thienopyrimidinone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H.
Journal of medicinal chemistry - 11 Jul 2013
Masaoka Takashi, Chung Suhman, Caboni Pierluigi, Rausch Jason W, Wilson Jennifer A, Taskent-Sezgin Humeyra, Beutler John A, Tocco Graziella, Le Grice Stuart F J
Abstract excerpt
The thienopyrimidinone 5,6-dimethyl-2-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4(3H)-one (DNTP) occupies the interface between the p66 ribonuclease H (RNase H) domain and p51 thumb of human immunodeficiency virus reverse transcriptase (HIV RT), thereby inducing a conformational change incompatible with catalysis. Here, we combined biochemical characterization of 39 DNTP derivatives with antiviral testing of selected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
